David A. Dresner

2017

In 2017, David A. Dresner earned a total compensation of $203.9K as Former Interim President and Chief Executive Officer at Osiris Therapeutics, a 9% decrease compared to previous year.

Compensation breakdown

Bonus$30,000
Salary$173,115
Other$834
Total$203,949
84.88%

Dresner received $173.1K in salary, accounting for 85% of the total pay in 2017.

Dresner also received $30K in bonus and $834 in other compensation.

Rankings

In 2017, David A. Dresner's compensation ranked 14,010th out of 14,666 executives tracked by ExecPay. In other words, Dresner earned more than 4.5% of executives.

ClassificationRankingPercentile
All
14,010
out of 14,666
5th
Division
Manufacturing
5,497
out of 5,772
5th
Major group
Chemicals And Allied Products
1,973
out of 2,075
5th
Industry group
Drugs
1,645
out of 1,731
5th
Industry
Biological Products, Except Diagnostic Substances
304
out of 313
3rd
Source: SEC filing on May 11, 2018.

Dresner's colleagues

We found six more compensation records of executives who worked with David A. Dresner at Osiris Therapeutics in 2017.

2017

Alla Danilkovitch

Osiris Therapeutics

Chief Scientific Officer

2017

Jason Keefer

Osiris Therapeutics

Chief Executive Officer

2017

Linda Palczuk

Osiris Therapeutics

Chief Executive Officer

2017

Linda Chang

Osiris Therapeutics

Chief Financial Officer

2017

Gregory Law

Osiris Therapeutics

Chief Financial Officer

2017

R Avendano

Osiris Therapeutics

Chief Medical Officer

You may also like